Evidence map›Paper›PMID 32110298›Full record

ArticleChemical science2019

Proline-promoted dehydroxylation of α-ketols.

Yelena Mostinski, David Lankri, Yana Konovalov, Riva Nataf, Dmitry Tsvelikhovsky

Abstract read
In one paragraph

Article in Chemical science, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yelena MostinskiThe Institute for Drug Research , Faculty of Medicine , The Hebrew University of Jerusalem , Jerusalem 9112102 , Israel . Email: dmitryt@ekmd.huji.ac.il.
David LankriThe Institute for Drug Research , Faculty of Medicine , The Hebrew University of Jerusalem , Jerusalem 9112102 , Israel . Email: dmitryt@ekmd.huji.ac.il.
Yana KonovalovThe Institute for Drug Research , Faculty of Medicine , The Hebrew University of Jerusalem , Jerusalem 9112102 , Israel . Email: dmitryt@ekmd.huji.ac.il.
Riva NatafThe Institute for Drug Research , Faculty of Medicine , The Hebrew University of Jerusalem , Jerusalem 9112102 , Israel . Email: dmitryt@ekmd.huji.ac.il.
Dmitry TsvelikhovskyThe Institute for Drug Research , Faculty of Medicine , The Hebrew University of Jerusalem , Jerusalem 9112102 , Israel . Email: dmitryt@ekmd.huji.ac.il.ORCID 0000-0002-1581-5291

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A new single-step proline-potassium acetate promoted reductive dehydroxylation of α-ketols is reported. We introduce the unexplored reactivity of proline and, for the first time, reveal its ability to function as a reducing agent. The developed metal-free and open-flask operation generally results in good yields. Our protocol allows the challenging selective dehydroxylation of hydroxyketones without affecting other functional groups.

Identifiers

PMID32110298
PMCPMC7006627

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.